These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 25373500)

  • 1. Carbonic anhydrase inhibitors: guaiacol and catechol derivatives effectively inhibit certain human carbonic anhydrase isoenzymes (hCA I, II, IX and XII).
    Scozzafava A; Passaponti M; Supuran CT; Gülçin İ
    J Enzyme Inhib Med Chem; 2015; 30(4):586-91. PubMed ID: 25373500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of hydroquinone on acetylcholine esterase and certain human carbonic anhydrase isoenzymes (hCA I, II, IX, and XII).
    Scozzafava A; Kalın P; Supuran CT; Gülçin İ; Alwasel SH
    J Enzyme Inhib Med Chem; 2015 Dec; 30(6):941-6. PubMed ID: 25586344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of a new series of N⁴-substituted 4-(2-aminoethyl)benzenesulfonamides and their inhibitory effect on human carbonic anhydrase cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
    Sławiński J; Brzozowski Z; Żołnowska B; Szafrański K; Pogorzelska A; Vullo D; Supuran CT
    Eur J Med Chem; 2014 Sep; 84():59-67. PubMed ID: 25016228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbonic anhydrase inhibitors: synthesis and inhibition of the human carbonic anhydrase isoforms I, II, VII, IX and XII with benzene sulfonamides incorporating 4,5,6,7-tetrabromophthalimide moiety.
    Sethi KK; Vullo D; Verma SM; Tanç M; Carta F; Supuran CT
    Bioorg Med Chem; 2013 Oct; 21(19):5973-82. PubMed ID: 23965175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbonic anhydrase inhibitors. Synthesis of a novel series of 5-substituted 2,4-dichlorobenzenesulfonamides and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
    Sławiński J; Pogorzelska A; Żołnowska B; Brożewicz K; Vullo D; Supuran CT
    Eur J Med Chem; 2014 Jul; 82():47-55. PubMed ID: 24871996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzenesulfonamide bearing 1,2,4-triazole scaffolds as potent inhibitors of tumor associated carbonic anhydrase isoforms hCA IX and hCA XII.
    SitaRam ; Celik G; Khloya P; Vullo D; Supuran CT; Sharma PK
    Bioorg Med Chem; 2014 Mar; 22(6):1873-82. PubMed ID: 24560737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of carbonic anhydrase isoforms I, II, IX and XII with secondary sulfonamides incorporating benzothiazole scaffolds.
    Petrou A; Geronikaki A; Terzi E; Guler OO; Tuccinardi T; Supuran CT
    J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1306-11. PubMed ID: 26745009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
    Sławiński J; Szafrański K; Vullo D; Supuran CT
    Eur J Med Chem; 2013 Nov; 69():701-10. PubMed ID: 24095761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 7-Aryl-triazolyl-substituted sulfocoumarins are potent, selective inhibitors of the tumor-associated carbonic anhydrase IX and XII.
    Nocentini A; Ceruso M; Carta F; Supuran CT
    J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1226-33. PubMed ID: 26681367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbonic anhydrase inhibitors. Inhibition of cytosolic isoforms I and II, and extracellular isoforms IV, IX, and XII with sulfamides incorporating sugar moieties.
    Colinas PA; Bravo RD; Vullo D; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2007 Sep; 17(18):5086-90. PubMed ID: 17658252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonic anhydrase inhibitors. Synthesis, molecular structures, and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with novel 3-pyridinesulfonamide derivatives.
    Brzozowski Z; Sławiński J; Gdaniec M; Innocenti A; Supuran CT
    Eur J Med Chem; 2011 Sep; 46(9):4403-10. PubMed ID: 21820216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of mammalian carbonic anhydrase isoforms I-XIV with a series of phenolic acid esters.
    Maresca A; Akyuz G; Osman SM; AlOthman Z; Supuran CT
    Bioorg Med Chem; 2015 Nov; 23(22):7181-8. PubMed ID: 26498394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationship with pyrazoline-based aromatic sulfamates as carbonic anhydrase isoforms I, II, IX and XII inhibitors: Synthesis and biological evaluation.
    Moi D; Nocentini A; Deplano A; Balboni G; Supuran CT; Onnis V
    Eur J Med Chem; 2019 Nov; 182():111638. PubMed ID: 31472471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbonic anhydrase inhibitors. Antioxidant polyphenols effectively inhibit mammalian isoforms I-XV.
    Innocenti A; Gülçin I; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5050-3. PubMed ID: 20674354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of Schiff base derivatives of 4-(2-aminoethyl)-benzenesulfonamide with inhibitory activity against carbonic anhydrase isoforms I, II, IX and XII.
    Durgun M; Turkmen H; Ceruso M; Supuran CT
    Bioorg Med Chem Lett; 2015 Jun; 25(11):2377-81. PubMed ID: 25913118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbonic anhydrase inhibitors. Regioselective synthesis of novel series 1-substituted 1,4-dihydro-4-oxo-3-pyridinesulfonamides and their inhibition of the human cytosolic isozymes I and II and transmembrane cancer-associated isozymes IX and XII.
    Brzozowski Z; Sławiński J; Vullo D; Supuran CT
    Eur J Med Chem; 2012 Oct; 56():282-91. PubMed ID: 22910138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of membrane-associated carbonic anhydrase isozymes IX, XII and XIV with a library of glycoconjugate benzenesulfonamides.
    Wilkinson BL; Bornaghi LF; Houston TA; Innocenti A; Vullo D; Supuran CT; Poulsen SA
    Bioorg Med Chem Lett; 2007 Feb; 17(4):987-92. PubMed ID: 17157501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides.
    Saczewski F; Innocenti A; Sławiński J; Kornicka A; Brzozowski Z; Pomarnacka E; Scozzafava A; Temperini C; Supuran CT
    Bioorg Med Chem; 2008 Apr; 16(7):3933-40. PubMed ID: 18242998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbonic anhydrase inhibitors: Synthesis, molecular docking, cytotoxic and inhibition of the human carbonic anhydrase isoforms I, II, IX, XII with novel benzenesulfonamides incorporating pyrrole, pyrrolopyrimidine and fused pyrrolopyrimidine moieties.
    Ghorab MM; Alsaid MS; Ceruso M; Nissan YM; Supuran CT
    Bioorg Med Chem; 2014 Jul; 22(14):3684-95. PubMed ID: 24878360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and evaluation of N-substituted saccharin derivatives as selective inhibitors of tumor-associated carbonic anhydrase XII.
    D'Ascenzio M; Carradori S; De Monte C; Secci D; Ceruso M; Supuran CT
    Bioorg Med Chem; 2014 Mar; 22(6):1821-31. PubMed ID: 24560739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.